These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11015010)

  • 21. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
    Mohini R
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical studies of recombinant human erythropoietin in patients on long-term dialysis].
    Ji SM; Li LS; Ji DX
    Zhonghua Nei Ke Za Zhi; 1993 Feb; 32(2):100-2. PubMed ID: 8404323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of ozonation by-products produced in drinking water treatment.
    Koga M; Akiyama T; Glaze WH
    Toxicol Ind Health; 1991; 7(5-6):423-32. PubMed ID: 1780885
    [No Abstract]   [Full Text] [Related]  

  • 25. Who should receive recombinant human erythropoietin?
    Van Stone JC
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):3-7. PubMed ID: 2669084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of erythropoietin treatment on urea kinetic parameters in hemodialysis patients.
    van Geelen JA; Nubé MJ; Zuurbier PA
    Clin Nephrol; 1991 Apr; 35(4):165-70. PubMed ID: 1855319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
    Zehnder C; Blumberg A
    Schweiz Med Wochenschr; 1990 Feb; 120(7):217-20. PubMed ID: 2309110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring considerations in recombinant human erythropoietin therapy.
    Ogden DA
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma vitamin E levels in a chronically hemolyzing group of dialysis patients.
    Cohen JD; Viljoen M; Clifford D; De Oliveria AA; Veriava Y; Milne FJ
    Clin Nephrol; 1986 Jan; 25(1):42-7. PubMed ID: 3955908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved sexual function in hemodialysis patients on recombinant erythropoietin: a possible role for prolactin.
    Schaefer RM; Kokot F; Wernze H; Geiger H; Heidland A
    Clin Nephrol; 1989 Jan; 31(1):1-5. PubMed ID: 2914405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes of enzyme activity levels in red blood cells in hemodialysis patients by recombinant human erythropoietin.
    Suzuki Y; Ogura Y; Otsubo O; Mimura N; Takaku F; Maeda T
    Nihon Jinzo Gakkai Shi; 1992 Sep; 34(9):1019-23. PubMed ID: 1479730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphologic and functional changes of left ventricle in dialyzed patients after treatment with recombinant human erythropoietin (r-HuEPO).
    Jeren-Struji'c B; Raos V; Jeren T; Horvatin-Godler S
    Angiology; 2000 Feb; 51(2):131-9. PubMed ID: 10701721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granular activated carbon usage in chloramine removal from dialysis water.
    Meyer MA; Klein E
    Artif Organs; 1983 Nov; 7(4):484-7. PubMed ID: 6651589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hundreds of partial pipe replacements conducted in Washington, DC before July 2004.
    Edwards MA
    Environ Res; 2011 Aug; 111(6):888; author reply 889. PubMed ID: 21737070
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: "Water disinfection by-products and pre labor rupture of membranes".
    Heitz A; Kristiana I
    Am J Epidemiol; 2009 Jan; 169(1):122-3; discussion 123. PubMed ID: 19033159
    [No Abstract]   [Full Text] [Related]  

  • 36. Water: keeping it clean for dialysis.
    Curtis J
    Nephrol News Issues; 2006; 20(5):11-2. PubMed ID: 16629365
    [No Abstract]   [Full Text] [Related]  

  • 37. [The after effect of r-HuEPO in treating anemic hemodialysis patients].
    Chu JQ
    Zhonghua Hu Li Za Zhi; 1994 Feb; 29(2):78-9. PubMed ID: 7788758
    [No Abstract]   [Full Text] [Related]  

  • 38. Improvements in quality of life following treatment with r-HuEPO in anemic hemodialysis patients.
    Delano BG
    Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):14-8. PubMed ID: 2757025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction of pancytopenia and hemochromatosis by r-huEPO in a hemodialysis patient.
    Agroyannis B; Koutsikos D; Tzanatou H; Yatzidis H
    Int J Artif Organs; 1992 Jul; 15(7):442. PubMed ID: 1516998
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of platelet function during treatment with recombinant human erythropoietin (r-HuEPO) in patients hemodialyzed and dialyzed peritoneally].
    Janicka L; Majdan M; Dmoszyńska A; Ksiazek A; Berger B; Baranowska E
    Wiad Lek; 1993 Oct; 46(19-20):756-60. PubMed ID: 7975620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.